Posted on 1月 11, 20221/11/22
A YEAR OF ACTION: Why Data-Backed, Integrated Commercialization Strategies Are Must-haves in 2022
Posted on 12月 22, 202112/22/21
Why Launching in Europe Is Unlike Launching Anywhere Else
Posted on 12月 16, 202112/16/21
Rx-to-OTC Switch Tips: Identifying the Right Timing, Conditions, and Approach for Rx-to-OTC Conversion
Posted on 11月 2, 202111/2/21
Bio-Europe “Collaboration Close-Up”: Exploring the EVERSANA – Shorla Pharma Partnership
Posted on 10月 14, 202110/14/21
Webinar: Discover Patient Support Program Needs for Patients with Rare Diseases
Posted on 10月 12, 202110/12/21
WEBINAR: A Pivotal Shift in Life Sciences Industry Across R&D and Commercial: A Conversation with the Experts
Posted on 10月 6, 202110/6/21
Bridging the Patient Support Gap With Integrated Technology Solutions and Strategies
Posted on 10月 1, 202110/1/21
A Data-Driven Commercialization Pathway to Expedite Rare Disease Diagnosis and Adherence
Posted on 9月 22, 20219/22/21